Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine)

Seiichi Kobayashi; Naoya Fujino; Satoshi Suzuki; Masaru Yanai

doi:10.1111/j.1440-1843.2009.01546.x

Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine)

Seiichi Kobayashi, Naoya Fujino, Satoshi Suzuki, Masaru Yanai

HOSP - Internal Medicine

Red Cross Ishinomaki Hospital

Research output: Contribution to journal › Article › peer-review

Abstract

Bronchioloalveolar carcinoma (BAC) is a distinct subtype of non-small cell lung cancer for which there is no optimal therapy for non-resectable or recurrent disease. This report describes a patient with BAC refractory to conventional chemotherapy but with a partial response to S-1, oral fluoropyrimidine, resulting in symptom improvement and weaning from oxygen supplementation. Our observation suggests that S-1 is a novel option for the treatment of advanced BAC.

Original language	English
Pages (from-to)	771-772
Number of pages	2
Journal	Respirology
Volume	14
Issue number	5
DOIs	https://doi.org/10.1111/j.1440-1843.2009.01546.x
Publication status	Published - 2009 Jul

Keywords

Bronchioloalveolar
Chemotherapy
Lung cancer
Refractory

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1440-1843.2009.01546.x

Cite this

@article{fec5693ee678427aadaf6369f37bb5d2,

title = "Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine)",

abstract = "Bronchioloalveolar carcinoma (BAC) is a distinct subtype of non-small cell lung cancer for which there is no optimal therapy for non-resectable or recurrent disease. This report describes a patient with BAC refractory to conventional chemotherapy but with a partial response to S-1, oral fluoropyrimidine, resulting in symptom improvement and weaning from oxygen supplementation. Our observation suggests that S-1 is a novel option for the treatment of advanced BAC.",

keywords = "Bronchioloalveolar, Chemotherapy, Lung cancer, Refractory",

author = "Seiichi Kobayashi and Naoya Fujino and Satoshi Suzuki and Masaru Yanai",

year = "2009",

month = jul,

doi = "10.1111/j.1440-1843.2009.01546.x",

language = "English",

volume = "14",

pages = "771--772",

journal = "Respirology",

issn = "1323-7799",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

TY - JOUR

T1 - Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine)

AU - Kobayashi, Seiichi

AU - Fujino, Naoya

AU - Suzuki, Satoshi

AU - Yanai, Masaru

PY - 2009/7

Y1 - 2009/7

N2 - Bronchioloalveolar carcinoma (BAC) is a distinct subtype of non-small cell lung cancer for which there is no optimal therapy for non-resectable or recurrent disease. This report describes a patient with BAC refractory to conventional chemotherapy but with a partial response to S-1, oral fluoropyrimidine, resulting in symptom improvement and weaning from oxygen supplementation. Our observation suggests that S-1 is a novel option for the treatment of advanced BAC.

AB - Bronchioloalveolar carcinoma (BAC) is a distinct subtype of non-small cell lung cancer for which there is no optimal therapy for non-resectable or recurrent disease. This report describes a patient with BAC refractory to conventional chemotherapy but with a partial response to S-1, oral fluoropyrimidine, resulting in symptom improvement and weaning from oxygen supplementation. Our observation suggests that S-1 is a novel option for the treatment of advanced BAC.

KW - Bronchioloalveolar

KW - Chemotherapy

KW - Lung cancer

KW - Refractory

UR - http://www.scopus.com/inward/record.url?scp=68149112263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68149112263&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1843.2009.01546.x

DO - 10.1111/j.1440-1843.2009.01546.x

M3 - Article

C2 - 19659655

AN - SCOPUS:68149112263

SN - 1323-7799

VL - 14

SP - 771

EP - 772

JO - Respirology

JF - Respirology

IS - 5

ER -

Successful treatment of refractory bronchioloalveolar carcinoma with S-1 (oral fluoropyrimidine)

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this